AI in Healthcare
The latest on artificial intelligence transforming medicine
News stories discovered and organized by an automated pipeline. Covering clinical deployments, research breakthroughs, regulation, and industry developments.
AI-Powered Handheld Microscope Could Bring Earlier Cancer Detection to the Point of Care
An AI-powered handheld microscope is being developed to spot cancer earlier, potentially bringing higher-resolution analysis to the point of care. The device is part of a broader push to move detection closer to patients instead of relying only on centralized pathology labs.
AI Pathology Tools Are Targeting the Cancer That Hides in Plain Sight
A new AI tool for pathologists claims to provide “spatial super vision” for finding hidden cancer in tissue samples. The development underscores how pathology is becoming a key frontier for AI, especially where subtle visual cues can alter diagnosis.
AI Tool Gives Pathologists 'Spatial Super Vision' to Detect Hidden Cancer
A new AI tool aims to help pathologists detect hidden cancer by giving them what its developers call 'spatial super vision.' The concept highlights how computational tools are increasingly being built to augment, rather than replace, human interpretation in pathology.
Roche’s reported $750M PathAI deal shows pathology AI moving from venture story to strategic asset
Roche’s reported acquisition of PathAI for $750 million signals how pathology AI is becoming strategically valuable to major diagnostics and life sciences companies. The deal would mark another step in the consolidation of AI assets around incumbents with distribution, data, and clinical reach.
AI is giving pathologists ‘spatial super vision’ — and hidden cancers may be the first beneficiaries
Medical Xpress reports on a screening tool that helps pathologists detect hidden cancer by adding a new spatial layer of insight. The key advance is not raw classification, but visual augmentation that makes subtle patterns easier to see. That makes pathology one of the most promising fields for agentic and assistive AI. It also shows how the best clinical AI may look less like automation and more like a second set of eyes.
Autonomous Pathology Research Suggests Agentic AI Could Reshape Oncology Workflows
Nature reports on agentic AI being used in autonomous pathology research, pointing to a future where models do more than classify images—they help plan and execute parts of the scientific workflow. The work is early, but it hints at a deeper transformation in how oncology research gets done.
Nature’s autonomous cancer pathology framework points to a new era of scientific discovery
A Nature paper on an agentic framework for autonomous scientific discovery in cancer pathology suggests AI is beginning to move upstream from analysis to hypothesis generation. If validated, this could change not only how pathology is interpreted, but how research questions themselves are discovered.
AI Improves Breast Cancer Pathology and Treatment Decisions, Study Suggests
A new News-Medical report highlights research suggesting AI can improve pathology interpretation and treatment decisions in breast cancer. The finding points to a broader opportunity: AI may be most valuable when it links imaging, pathology, and therapeutic planning rather than working in isolation.
AI Pathology System Promises Multi-Cancer Diagnosis Without Extra Training
Researchers at HKUST say they have developed an AI pathology system that can diagnose multiple cancers precisely without additional model training. If validated, the approach could reduce the effort needed to deploy pathology AI across different tumor types.
AI Cancer Screening Crosses a New Threshold as Plug-and-Play Models Reach 18 Tumor Types
A new plug-and-play AI system reportedly identifies 18 cancer types from just a small number of pathology slides, suggesting cancer detection models are becoming more generalizable across tumor types. If validated broadly, the approach could lower the barrier to deploying AI in pathology labs.
LLMs Can Summarize Cancer Pathology Better Than Doctors, Raising the Stakes for Clinical Workflow AI
A report from healthcare-in-europe.com suggests large language models can outperform physicians at summarizing complex cancer pathology reports. The result highlights where AI may add value today: not in replacing expert judgment, but in compressing dense information into more usable form.
AI is pushing breast cancer care from image reading toward full-pathway decision support
A new Cureus review argues that AI is becoming relevant across the breast cancer care continuum, from detection and pathology to prognostication and treatment planning. The literature now points to a broader clinical role than single-task image classification.
AI in pathology is becoming the new center of gravity for breast cancer detection and prognosis
Devdiscourse reports that AI-driven pathology is reshaping how breast cancer is detected and prognosticated. The trend suggests pathology may become one of the most consequential, and least flashy, areas of medical AI.
Breast Cancer AI Is Entering the Pathology Lab — and the Real-World Questions Are Getting Harder
Medical News Today highlights the tension between AI’s promise in melanoma and the realities of clinical deployment, while Devdiscourse points to AI-driven pathology reshaping breast cancer detection and prognosis. Together, they underscore a field moving from proof-of-concept toward questions of trust, integration, and accountability.
AI in Pathology Is Becoming the Quiet Engine of Oncology
Medscape’s look at AI in oncology pathology highlights a field that may be less visible than radiology, but just as important. Pathology sits at the center of diagnosis, grading, and treatment selection, making it a natural place for AI to influence care. The real opportunity is not just automation, but better prioritization and more consistent interpretation.
AI Pathology Is Becoming the New Growth Engine in Oncology
Medscape’s look at pathology in oncology argues that AI is shifting cancer diagnostics from pixels to prescriptions. The story is less about a single breakthrough than about a broader restructuring of how cancer information is interpreted and acted on.
AI Outperforms Doctors at Summarizing Complex Cancer Pathology Reports
A new report suggests AI can summarize complex cancer pathology reports better than physicians in certain settings. The finding highlights where generative AI may offer immediate value: not in replacing pathology, but in making dense medical language usable downstream.
NHS one-day prostate cancer diagnosis push shows AI’s value may be speed as much as accuracy
A report that the NHS could offer a prostate cancer diagnosis within a day using AI points to a critical but often underappreciated benefit of clinical AI: compressing diagnostic timelines. In cancer care, reducing waiting time can be as strategically important as improving raw detection performance.
Labcorp and PathAI Push AI Digital Pathology Into Routine U.S. Diagnostics
Labcorp has expanded its partnership with PathAI to deploy the FDA-cleared AISight Dx platform across its U.S. anatomical pathology network and participating hospitals. The move is significant because it shifts AI pathology from pilot-stage promise toward scaled operational use in routine diagnostics, with implications for turnaround time, consistency, and downstream biomarker-driven care.
How this works
Discover
An automated pipeline searches the web for significant AI healthcare news across clinical, research, regulatory, and industry domains.
Structure
The pipeline turns source material into concise, readable stories with categories, tags, and context that make the feed easier to scan.
Publish
Stories are deduplicated, stored, and published to this site. The pipeline runs automatically to keep coverage current.